Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study

Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study

IntroductionMigraine is a highly prevalent and disabling neurological disease. Excessive use of acute medications can lead to medication-overuse headache (MOH), occurring when a patient experiences an increasing number of headache and migraine days, despite taking greater amounts of acute medication...

Full description

Bibliographic Details
Main Authors: Rigmor H. Jensen, Henrik Winther Schytz, Cristina Tassorelli, Gisela M. Terwindt, Louise N. Carlsen, Aurélia Mittoux, Ole Østerberg, Richard B. Lipton, Stewart J. Tepper, Andrew Blumenfeld, Christofer Lundqvist
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Neurology
Subjects:
migraine
preventive medicine
protocols and guidelines
medication-overuse headache
eptinezumab
Brief Educational Intervention
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1114654/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1114654/full

Similar Items